Today’s blog is from Ahmed Alharthi, who in undertaking a PhD at the University of Glasgow. Ahmed talks about the PhD journey.

I am a licenced clinical pharmacist by background, who works with Dr Terry Quinn, a consultant physician and geriatrician in the NHS and a reader in Geriatric Medicine department at the University of Glasgow. I am a second year PhD student, employed and sponsored by Umm Al Qura University in Saudi Arabia.

I completed my MSc in Clinical Pharmacology at the University of Glasgow, and then started to pursue my PhD in Cardiovascular Medicine. My PhD title is “Repurposing cardiovascular medicines for vascular dementia – a data driven clinical study”. My PhD work so far has focussed on dementia and associations with a group of medications called Anticholinergic drugs. I wish to understand the potential relationship between these commonly used medications and the incidence of dementia in older adults, because if there is a causal relationship this could suggest a potential modifiable risk factor.

In my work so far, I have conducted systemic reviews focused on evidence synthesis and had the opportunity to collaborate with the Cochrane Dementia Group, resulting in published paper. I am currently working on a dataset from a completed cohort the APPLE study. This offers me participant-level data that contain high-quality information on medications prescribed and consumed, with detailed information on changes in medication over time. This level of detail is often missing in studies that contain information on prescribed medications, but to truly understand the relationship between medications and dementia this granularity of medication data is required.

Given my professional background, I was eager for my PhD to include content related to clinical pharmacy practice. Among the ideas I have discussed with my supervisors are a real-world analysis of anticholinergic prescribing in Greater Glasgow and Clyde secondary care and a qualitative piece contrasting prescribers’ opinions on anticholinergic prescribing and the use of scales to identify anticholinergic risk.

I was motivated towards pursuing a PhD with a cognition and medications focus, as I was aware of the crucial role of clinical pharmacy to enhance medications use and possibly to improve cognitive impairment by adopting novel treatment approaches.

I am especially excited around the next step of my research, working with Dr Donald Lyall, my second supervisor. I will move from a relatively large dataset (APPLE Study) to a truly bigdata project, assessing for associations of cardiovascular medications and dementia in the UK Biobank, one of the largest biomedical databases in the world.

I am keen to engage with the Scottish dementia research community and look forward to meeting other researchers.

Read more SDRC Blogs

COVID Impact on ECRs: Maria Drummond

In the coming days, the SDRC are publishing a series of blogs featuring Early Career Researchers who are sharing how COVID has impacted their research and career prospects. Today's blog is by Maria Drummond, PhD Student at the University of Glasgow My name is Maria...

Dementia Awareness Week 2023

Each year, Dementia Awareness Week (DAW) is held with the aim of raising awareness of dementia and helping improve the lives of people with dementia, their families, and carers. Find out more about Dementia Awareness Week on the Alzheimer Scotland website. In 2023,...

COVID Impact on ECRs: Miriam Scarpa

In the coming days, the SDRC are publishing a series of blogs featuring Early Career Researchers who are sharing how COVID has impacted their research and career prospects. The first blogs in this series also featured in our COVID Research Impact Report which we...

COVID Impact on ECRs: Tharin Phenwan

This week on the SDRC blog we are continuing our Early Career Researcher blog series on the impact of COVID.  Today's blog is by Tharin Phenwan. You can read the entire blog series here. My name is Tharin Phenwan. I am a second-year PhD student at the University of...

Early Career Researchers: Shaun Stone

We start off the fourth week of the SDRC's blog series on Early Career Researchers from Shaun Stone from the University of Aberdeen. Shaun's research relates to the SDRC's Diagnosis theme, which you can find out more about here. Shaun Stone is a final year PhD ERC...

COVID Impact on ECRs: Michael Smith

In the coming days, the SDRC are publishing a series of blogs featuring Early Career Researchers who are sharing how COVID has impacted their research and career prospects.  Today's blog is by Michael Smith, a PhD student from UWS. A Deep roots are not reached by the...

International Researcher: Ariel Frame

Today, the SDRC goes international! This guest blog is form Ariel K. Frame, PhD Candidate from the neuroscience graduate program at Western University, London, Ontario, Canada. Ariel tells us about research and a desire to work in Scotland.     I am a neurobiologist...

Alzheimer Scotland Student Research Programme announces first MRes student

The Alzheimer Scotland Student Research Programme is excited to announce our first ever MRes student: Kelly Kelly. Kelly’s studentship is hosted by the Alzheimer Scotland Centre for Policy and Practice at the University of the West of Scotland. She is supervised by Dr...

That’s a good idea!

At SDRC we have been speaking to different people about their experiences of involvement in dementia research and are delighted to be publishing a series of blogs, sharing tips and lessons for us all. Our first blog in this new Research Involvement series is from...

How to organise a virutal conference: Our experience from the SDRC Conference 2020

The SDRC’s first ever virtual annual conference took place earlier this month. It was our first ever all-virtual event and, I am pleased to say, feedback has been positive. As much as we love face-to-face events, there is still uncertainty as to when and to what...